Related Experiment Video
Updated: May 9, 2026
08:27
Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
Messenger RNA-based vaccines: progress, challenges, applications.
1BioNTech AG, Mainz, Germany.
Wiley Interdisciplinary Reviews. RNA
|July 30, 2013
Summary
Messenger RNA (mRNA) vaccines demonstrate specific protection against viral infections in animals, paving the way for human clinical trials. This adaptable platform offers safety, synthetic production, and potent immune responses for prophylactic vaccines.
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Background:
- Messenger RNA (mRNA) vaccines have evolved significantly since their initial demonstration of immunogenicity.
- Recent advancements show successful proof-of-concept for protection against viral infections in various animal models.
Purpose of the Study:
- To highlight the potential of mRNA-based vaccines for infectious disease prophylaxis.
- To encourage the translation of mRNA vaccine technology into human clinical trials.
- To review the design, mechanism, and capabilities of current mRNA vaccines, using influenza prophylaxis as a case study.
Main Methods:
- Review of existing literature and data on mRNA vaccine development and efficacy.
- Focus on the conceptual advantages of mRNA vaccines over other genetic vectors.
- Analysis of the immunological properties and production methods of mRNA vaccines.
Main Results:
- mRNA vaccines provide specific protection against viral infections in animal models.
- mRNA vaccines are molecularly defined, synthetically produced, and rapidly degraded, ensuring safety and control.
- They can activate the innate immune system, induce balanced immune responses (B cells, T cells), and allow for in situ antigen formation.
Conclusions:
- mRNA-based vaccines represent a versatile and promising platform for prophylactic applications in infectious diseases.
- Their inherent safety, ease of production, and tailored immunogenicity support their advancement into human trials.
- The technology holds significant potential, particularly demonstrated by its application in influenza prophylaxis.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...